Martin Fey

Suggest Changes
Learn More
BACKGROUND Predictive factors of rituximab efficacy and its effect on the immune system are still not defined. PATIENTS AND METHODS Three hundred and six patients with follicular or mantle cell(More)
PURPOSE To retrospectively determine the outcome of acute promyelocytic leukemia (APL) patients who underwent autologous or allogeneic stem-cell transplantation (SCT) during second complete(More)
PURPOSE The aim of this prospective randomized trial was to examine the efficacy and safety of filgrastim after high-dose chemotherapy and autologous bone marrow transplantation (ABMT). PATIENTS(More)
Mantle cell lymphoma (MCL) shares immunophenotypic and karyotypic features with chronic lymphocytic leukaemia. The latter comprises two distinct entities with prognosis dependent upon immunoglobulin(More)